High levels of endothelin (ET)-1 and aneurysm diameter independently predict growth of stable abdominal aortic aneurysms

Angiology

Volumn 61, Issue 4, 2010, Pages 324-328

  Flondell Sité, Despina ^a   Lindblad, Bengt ^a   Gottsäter, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Abdominal aortic aneurysm; CD40 ligand; Endothelin 1; Growth; Inflammation; Interleukin 6; Statin; Tumor necrosis factor

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; CD40 LIGAND; CREATININE; ENDOTHELIN 1; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA;

ABDOMINAL AORTA ANEURYSM; AGED; ANEURYSM GROWTH; ANEURYSM SURGERY; ARTERY DIAMETER; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DRUG USE; FEMALE; GROWTH RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTION; PROTEIN BLOOD LEVEL;

EID: 77952710858     PISSN: 00033197     EISSN: None     Source Type: Journal    
DOI: 10.1177/0003319709344190     Document Type: Article

References (32)

1. Wassef M., Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg. 2001; 34 (4). 730-738.
2. Vainas T., Lubbers T., Stassen FR, et al. Serum C-reactive protein level is associated with abdominal aortic aneurysm size and may be produced by aneurysmal tissue. Circulation. 2003; 107 (8). 1103-1105.
3. Lindblad B., Börner G., Gottsäter A. Factors associated with development of large abdominal aortic aneurysm in middle-aged men. Eur J Vasc Endovasc Surg. 2005; 30 (4). 346-352.
4. Lindholt JS, Shi G.-P. Chronic inflammation, immune response and infection in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 2006; 31 (5). 453-463.
5. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm pathogenesis and implications for management. Art Thromb Vasc Biol. 2006; 26 (12). 2605-2619.
6. Schlösser FJV, Tangelder MJD, Verhagen HJM, et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg. 2008; 47 (6). 1127-1133.
7. Urbonavicius S., Urbonaviciene G., Honoré B., Henneberg EW, Vorum H., Lindholt JS Potential circulating biomarkers for abdominal aortic aneurysm expansion and rupture-a systematic review. Eur J Vasc Endovasc Surg. 2008; 36 (3). 273-280.
8. Middleton RK, Lloyd GM, Bown MJ, Cooper NJ, London NJ, Sayers RD The pro-inflammatory and chemotactic cytokine microenvironment of the abdominal aortic aneurysm wall: a protein array study. J Vasc Surg. 2007; 45 (3). 574-580.
9. Hamano K., Li TS, Takahashi M., et al. Enhanced tumor necrosis factor-alpha expression in small sized abdominal aortic aneurysms. World J Surg. 2003; 27 (4). 476-480.
10. Dawson J., Cockerhill GW, Choke E., Belli AM, Loftus I., Thompson MM Aortic aneurysms secrete interleukin-6 into the circulation. J Vasc Surg. 2007; 45 (2). 350-356.
11. Kishimoto T. The biology of interleukin-6. Blood. 1989; 74 (1). 1-10.
12. Kälsch T., Nguyen XD, Elmas E., et al. Coagulation activation and expression of CD40 ligand on platelets upon in vitro lipopolysaccharide- challenge in patients with unstable angina. Int J Cardiol. 2006; 111 (2). 217-223.
13. Schönbeck U., Libby P. CD40 signaling and plaque instability. Circ Res. 2001; 89 (12). 1092-1103.
14. Schönbeck U., Gerdes N., Varo N., et al. Oxidized low-density lipoprotein augments and 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors limit CD40 and CD40L expression in human vascular cells. Circulation. 2002; 106 (23). 2888-2893.
15. Newby DE, Webb DJ The endothelin system in cardiovascular disease. BMJ. 1997; 314 (7080). 531-532.
16. Ikeda U., Yamamoto K., Maeda Y., Shimpo M., Kanbe T., Shimada K. Endothelin-1 inhibits nitric oxide synthesis in vascular smooth muscle cells. Hypertension. 1997; 29 (1 pt 1). 65-69. (Pubitemid 27078343) (Pubitemid 27078343)
17. Třeška V., Wenham PJ, Valenta J., TopolÄ an O., Pecen L. Plasma endothelin levels in patients with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg. 1999; 17 (5). 424-428.
18. Wagner A., Domanovits H., Holzer M., et al. Plasma endothelin in patients with acute aortic disease. Resuscitation. 2002; 53 (1). 71-76. (Pubitemid 34310212) (Pubitemid 34310212)
19. Schouten O., van Laanen JH, Boersma E., Vidakovic R., Feringa HH, Dunkelgrun M. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg. 2006; 32 (1). 21-26.
20. Golledge J., Karan M., Moran CS, et al. Reduced expansion rate of abdominal aortic aneurysms in patients with diabetes may be related to aberrant monocyte-matrix interactions. Eur Heart J. 2008; 29 (5). 665-672.
21. Barton M. Endothelial dysfunction and atherosclerosis: endothelin receptor antagonists as novel therapeutics. Curr Hypertens Rep. 2000; 2 (1). 84-91.
22. Adam DJ, Evans SM, Webb DJ, Bradbury AW Plasma endothelin levels and outcome in patients undergoing repair of ruptured infrarenal abdominal aortic aneurysms. J Vasc Surg. 2001; 33 (6). 1242-1246.
23. Solberg S., Singh K., Wilsgaard T., Jacobsen BK Increased growth rate of abdominal aortic aneurysms in women The TromsÃ̧ study. Eur J Vasc Endovasc Surg. 2005; 29 (2). 145-149.
24. Brady AR, Thompson SG, Fowkes FG, Greenhalgh RM, Powell JT Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation. 2004; 110 (1). 16-21.
25. Brown PM, Sobolev B., Zelt DT Selective management of abdominal aortic aneurysms smaller than 5.0 cm in a prospective sizing program with gender-specific analysis. J Vasc Surg. 2003; 38 (4). 762-765.
26. Gottsäter A., Flondell-Sité D., Kölbel T., Lindblad B. Associations between statin treatment and markers of inflammation, vasoconstriction and coagulation in patients with abdominal aortic aneurysm. Vasc Endovasc Surg. 2009; 42 (6). 567-573.
27. Sukhija R., Aronow WS, Sandhu R., Kakar P., Babu S. Mortality and size of abdominal aortic aneurysm at long term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol. 2006; 97 (2). 279-280.
28. Bigatel DA, Elmore JR, Carey DJ, Cizmeci-Smith G., Franklin DP, Youkey JR The matrix metalloproteinase inhibitor BB-94 limits expansion of experimental abdominal aortic aneurysms. J Vasc Surg. 1999; 29 (1). 130-138.
29. Thompson RW, Baxter T. MMP inhibition in abdominal aortic aneurysms: rationale for a prospective randomized clinical trial. Ann NY Acad Sci. 1999; 878 (1). 159-178.
30. Nagashima H., Aoka Y., Sakomura Y., et al. Matrix metalloproteinase 2 is suppressed by trapidil, a CD40-CD40 ligand pathway inhibitor, in human abdominal aortic aneurysm wall. J Vasc Surg. 2004; 39 (2). 447-453.
31. Barton M., Yanagisawa M. Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol. 2008; 86 (8). 485-498.
32. Pearl JD, Macdonald RL Clazosentan reduced angiographic vasospasm in a dose-dependent manner in patients with aneurysmal SAH following coiling or clipping of the aneurysm. Acta Neurochir. 2008; 105 (suppl. 00651419). 207-210.